#209 | 5 Lessons You Should Know Before Commercializing & Exporting Your MedTech Product (For Clinicians)

So in this episode, you're gonna learn the five lessons every MedTech founder should know before taking a product to market Welcome to Clinician to CEO, the podcast helping clinicians simplify your go-to-market strategy so that you can stop guessing and turn your working prototypes into international MedTech businesses. I'm your host, Hakeem Aade. Let's get started. So the three things that you're gonna discover in this episode is, number one, why solving a clinical problem isn't enough to guarantee adoption.

Number two, how to build commercial thinking into your product from day one. And number three, the mindset shifts that separate successful med tech founders from everyone else. Over the next few minutes, I'm gonna share the five biggest lessons that I took away from my conversation with Jordan Morrison. So let's get straight into it Takeaway number one is solving a problem unfortunately isn't enough, and Jordan introduced us to what she calls the ugly baby syndrome.

Because as founders, it's really easy to believe that because we've experienced a problem ourselves, everyone else will want the same solution But solving a clinical problem doesn't automatically create a commercial opportunity, cause the real question isn't whether it's a problem, it's whether, as I've said many times, it's a priority that people are willing to change Behavior, budget, and workflows to solve. So the action I want you to do here is to ask yourself, if you weren't the inventor, would you still build this product?

If you're not sure, then it's time to validate the market a bit further before investing any more time or any more money. to takeaway number two, commercialization starts on day one. One of the strongest messages that came through the podcast was that too many founders see regulatory approval as the finish line, and it isn't. It's the starting line, and we've said this a load of time before, and you know it.

Getting regulatory approval doesn't guarantee adoption. You still need customers. You still need a route to market. You still need this pricing strategy, and you need a commercial plan.

The most successful founders think about all of those things from the very beginning, not after regulatory approval has been achieved. So the action point here is ask yourself, if you receive regulatory approval tomorrow, what would happen next? And if you don't have a clear answer, then it's critical that you start to spend as much time on your commercial strategy as you are doing on your regulatory strategy. That moves us on to takeaway number three, funding is market validation, and this is probably one of my favorite insights from the whole of the conversation, cause Jordan encourages founders to seek early investment from clinicians in the specialty that they're trying to serve.

Why? Because if the people who eventually are going to use your product won't invest in it, then why should anyone else? Funding shouldn't be, and isn't just about raising capital. It should be one of the strongest forms of market validation that you can get, and the action point here is for you to ask yourself who are the first five people that you'd ask to back this idea?

And more importantly, would they actually say yes? Moving On to takeaway number four, leave your ego at the door. There was something that Jordan said that really resonated with me, and that was that the best founders are coachable. They seek People who challenge their thinking, and they don't surround themselves with people who just tell them what they want to hear.

You know, yes men is I think the normal term that we talk about. What the best founders do is they surround themselves with people who are willing to tell them when they're wrong, because that's how better products get built. You should be agnostic about the ideas, as we said in, in the podcast. You just need to get to the right ideas.

So the action point here is ask yourself who regularly challenges your thinking. And if nobody comes to mind, you probably need more people around you who will tell you the truth and not just agree with you. So moving on to the fifth and final takeaway, and that was keep moving forward. And it's really nice 'cause Jordan finished with a message that applies to every founder, and that was that most med tech companies don't fail because they have bad ideas.

They fail because they stop moving. They get stuck. They start waiting for more evidence, more funding, a better product, the perfect strategy. As we've said on numerous podcasts, progress beats perfection every single time.

And the action point here is I want you to ask yourself, what's the best decision that you can make that moves your product or service forward? And then make it. Don't procrastinate, just make it. Because momentum creates opportunities, standing still doesn't.

And if there's one thing that I took away from my conversation with Jordan, it's this, successful med tech companies don't just build products, they build a path to adoption. And that means validating your assumptions early, thinking commercially from day one, being willing to listen, being willing to pivot, and never letting perfection become the enemy of progress. Because at the end of the day, a brilliant product only changes lives if somebody actually adopts it And if you're building a MedTech business and you're not sure whether your next move should be around evidence, market access, commercialization, distributor strategy.

Or adoption. Do not guess. Book a healthcare export accelerator diagnostic Call with me. Use my link in the show notes.

And in that session I'll help you identify the specific constraints blocking your momentum and the commercial move most likely to unlock your progress. Thanks for tuning in. Until next time, thanks for listening. Keep challenging your assumptions and keep growing.